Covered recipient · General Payments record
NIMA KOURANG-BEHESHTI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$42,164.09
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,127.85 | 4 |
| Food and Beverage | $354.16 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $1,194.10 | 5 |
| ABBVIE INC. | $204.02 | 10 |
| EISAI INC. | $43.13 | 2 |
| GENZYME CORPORATION | $24.97 | 1 |
| PFIZER INC. | $15.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $194.95 | 03/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125382338 | CMS |
| Abbott Laboratories | $66.25 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124789383 | CMS |
| Abbott Laboratories | $351.92 | 03/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125382340 | CMS |
| Abbott Laboratories | $571.96 | 05/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125382336 | CMS |
| Abbott Laboratories | $9.02 | 05/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1125382342 | CMS |
| ABBVIE INC. | $34.34 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103722 | CMS |
| ABBVIE INC. | $18.77 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103724 | CMS |
| ABBVIE INC. | $15.38 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103726 | CMS |
| ABBVIE INC. | $17.50 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103728 | CMS |
| ABBVIE INC. | $12.17 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103730 | CMS |
| ABBVIE INC. | $15.48 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103732 | CMS |
| ABBVIE INC. | $20.82 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103734 | CMS |
| ABBVIE INC. | $31.61 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103736 | CMS |
| ABBVIE INC. | $15.73 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103738 | CMS |
| ABBVIE INC. | $22.22 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104103740 | CMS |
| Eisai Inc. | $20.30 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110770415 | CMS |
| Eisai Inc. | $22.83 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110770417 | CMS |
| GENZYME CORPORATION | $24.97 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139866984 | CMS |
| PFIZER INC. | $15.79 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130877534 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.